相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of Fibroblast Growth Factor 19 Is Associated with Recurrence and Poor Prognosis of Hepatocellular Carcinoma
Jiyeon Hyeon et al.
DIGESTIVE DISEASES AND SCIENCES (2013)
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma
Tokuzo Arao et al.
HEPATOLOGY (2013)
Fibroblast growth factor 19 expression correlates with tumor progression and poorer prognosis of hepatocellular carcinoma
Seiki Miura et al.
BMC CANCER (2012)
AZD4547: An Orally Bioavailable, Potent, and Selective Inhibitor of the Fibroblast Growth Factor Receptor Tyrosine Kinase Family
Paul R. Gavine et al.
CANCER RESEARCH (2012)
Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells
Hinako Tsunematsu et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Dovitinib demonstrates antitumor and antimetastatic activities in xenograft models of hepatocellular carcinoma
Hung Huynh et al.
JOURNAL OF HEPATOLOGY (2012)
Targeting FGFR4 Inhibits Hepatocellular Carcinoma in Preclinical Mouse Models
Dorothy M. French et al.
PLOS ONE (2012)
Impact of Fibroblast Growth Factor-Binding Protein-1 Expression on Angiogenesis and Wound Healing
Elena Tassi et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Fibroblast growth factors and their receptors in cancer
Jorgen Wesche et al.
BIOCHEMICAL JOURNAL (2011)
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro
G. Wu et al.
BRITISH JOURNAL OF CANCER (2011)
Identification of a Therapeutic Strategy Targeting Amplified FGF19 in Liver Cancer by Oncogenomic Screening
Eric T. Sawey et al.
CANCER CELL (2011)
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma
Fumihiko Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Up-Regulation of the Fibroblast Growth Factor 8 Subfamily in Human Hepatocellular Carcinoma for Cell Survival and Neoangiogenesis
Christine Gauglhofer et al.
HEPATOLOGY (2011)
Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase
Vito Guagnano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
FGF-2 Regulates Cell Proliferation, Migration, and Angiogenesis through an NDY1/KDM2B-miR-101-EZH2 Pathway
Filippos Kottakis et al.
MOLECULAR CELL (2011)
Development of Molecularly Targeted Therapies in Hepatocellular Carcinoma: Where Do We Go Now?
Richard S. Finn
CLINICAL CANCER RESEARCH (2010)
Synergistic Role of Sprouty2 Inactivation and c-Met Up-Regulation in Mouse and Human Hepatocarcinogenesis
Susie A. Lee et al.
HEPATOLOGY (2010)
Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
Huating Li et al.
JOURNAL OF HEPATOLOGY (2010)
A Novel Mechanism of Sequestering Fibroblast Growth Factor 2 by Glypican in Lipid Rafts, Allowing Skeletal Muscle Differentiation
Jaime Gutierrez et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Fibroblast growth factor signalling: from development to cancer
Nicholas Turner et al.
NATURE REVIEWS CANCER (2010)
Signal co-operation between integrins and other receptor systems
Charles H. Streuli et al.
BIOCHEMICAL JOURNAL (2009)
Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice
Jing Qing et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Resident Hepatocyte Fibroblast Growth Factor Receptor 4 Limits Hepatocarcinogenesis
Xinqiang Huang et al.
MOLECULAR CARCINOGENESIS (2009)
Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma
Jin-Ping Lai et al.
HEPATOLOGY (2008)
Chondroitin sulfate and heparan sulfate-containing proteoglycans are both partners and targets of basic fibroblast growth factor-mediated proliferation in human metastatic melanoma cell lines
D. Nikitovic et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
Scott M. Wilhelm et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Targeting FGF19 inhibits tumor growth in colon cancer xenograft and FGF19 transgenic hepatocellular carcinoma models
Lr Desnoyers et al.
ONCOGENE (2008)
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys
Haijun D. Sun et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Fibroblast growth factor-2-induced host stroma reaction during initial tumor growth promotes progression of mouse melanoma via vascular endothelial growth factor A-dependent neovascularization
Satoshi Tsunoda et al.
CANCER SCIENCE (2007)
Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis
Xinqiang Huang et al.
MOLECULAR CARCINOGENESIS (2006)
The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells
Suzanne Trudel et al.
BLOOD (2006)
Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis
XQ Huang et al.
CANCER RESEARCH (2006)
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
O Casanovas et al.
CANCER CELL (2005)
Mechanisms underlying differential responses to FGF signaling
L Dailey et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Acyclic retinoid inhibits human hepatoma cell growth by suppressing fibroblast growth factor-mediated signaling pathways
RX Shao et al.
GASTROENTEROLOGY (2005)
FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts
N Gotoh et al.
FEBS LETTERS (2004)
Sef is a spatial regulator for Ras/MAP kinase signaling
S Torii et al.
DEVELOPMENTAL CELL (2004)
Evolution of the Fgf and Fgfr gene families
N Itoh et al.
TRENDS IN GENETICS (2004)
Role of fibroblast growth factor type 1 and 2 in carbon tetrachloride-induced hepatic injury and fibrogenesis
CD Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs
SK Olsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis
JA Holt et al.
GENES & DEVELOPMENT (2003)
Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation
D Kovalenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice
CD Yu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
A mouse model of hepatocellular carcinoma - Ectopic expression of fibroblast growth factor 19 in skeletal muscle of transgenic mice
K Nicholes et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma
RTP Poon et al.
AMERICAN JOURNAL OF SURGERY (2001)
Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin
L Pellegrini et al.
NATURE (2000)
Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice
DL Miller et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
